126 related articles for article (PubMed ID: 6725078)
21. Relaxant activity of atriopeptins in isolated guinea pig airway and vascular smooth muscle.
O'Donnell M; Garippa R; Welton AF
Peptides; 1985; 6(4):597-601. PubMed ID: 2933640
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.
Nandiwada PA; Kadowitz PJ; Said SI; Mojarad M; Hyman AL
J Appl Physiol (1985); 1985 May; 58(5):1723-8. PubMed ID: 3997734
[TBL] [Abstract][Full Text] [Related]
23. Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.
O'Donnell M; Garippa RJ; Rinaldi N; Selig WM; Simko B; Renzetti L; Tannu SA; Wasserman MA; Welton A; Bolin DR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1282-8. PubMed ID: 7932180
[TBL] [Abstract][Full Text] [Related]
24. Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier.
Jia L; Stamler JS
Eur J Pharmacol; 1999 Jan; 366(1):79-86. PubMed ID: 10064155
[TBL] [Abstract][Full Text] [Related]
25. Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxation.
Venugopalan CS; Said SI; Drazen JM
Respir Physiol; 1984 May; 56(2):205-16. PubMed ID: 6463427
[TBL] [Abstract][Full Text] [Related]
26. [Vasoactive intestinal peptide inhibits vagal neuro-effector transmission in feline airway smooth muscle but not in humans].
Aizawa H; Inoue H; Koto H; Ikeda T; Hirose T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Nov; 29(11):1425-31. PubMed ID: 1663178
[TBL] [Abstract][Full Text] [Related]
27. Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries.
Greenberg B; Rhoden K; Barnes PJ
Blood Vessels; 1987; 24(1-2):45-50. PubMed ID: 3567364
[TBL] [Abstract][Full Text] [Related]
28. Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways.
Chow JM; Moffatt JD; Cocks TM
Br J Pharmacol; 2000 Dec; 131(8):1584-91. PubMed ID: 11139435
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus.
Dick JM; Van Geldre LA; Timmermans JP; Lefebvre RA
Br J Pharmacol; 2000 Feb; 129(4):751-63. PubMed ID: 10683200
[TBL] [Abstract][Full Text] [Related]
30. Effect of vasoactive intestinal polypeptide (VIP) on cyclic AMP level and relaxation in rat isolated aorta.
Schoeffter P; Stoclet JC
Eur J Pharmacol; 1985 Feb; 109(2):275-9. PubMed ID: 2986998
[TBL] [Abstract][Full Text] [Related]
31. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways.
Gruetter CA; Childers CE; Bosserman MK; Lemke SM; Ball JG; Valentovic MA
Am Rev Respir Dis; 1989 May; 139(5):1192-7. PubMed ID: 2496634
[TBL] [Abstract][Full Text] [Related]
32. A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle.
Bai TR; Mak JC; Barnes PJ
Am J Respir Cell Mol Biol; 1992 Jun; 6(6):647-51. PubMed ID: 1317193
[TBL] [Abstract][Full Text] [Related]
33. New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody.
Berisha HI; Bratut M; Bangale Y; Colasurdo G; Paul S; Said SI
Pulm Pharmacol Ther; 2002; 15(2):121-7. PubMed ID: 12090785
[TBL] [Abstract][Full Text] [Related]
34. Adrenergic and VIP-ergic relaxatory mechanisms of the feline extrahepatic biliary tree.
Dahlstrand C; Dahlström A; Ahlman H
J Auton Nerv Syst; 1989 Mar; 26(2):97-106. PubMed ID: 2723339
[TBL] [Abstract][Full Text] [Related]
35. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
Goossens JF; Pommery N; Lohez M; Pommery J; Helbecque N; Cotelle P; Lhermitte M; Henichart JP
Mol Pharmacol; 1992 Jan; 41(1):104-9. PubMed ID: 1732717
[TBL] [Abstract][Full Text] [Related]
36. Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea.
Venugopalan CS; Holmes EP; O'Malley NA
J Auton Pharmacol; 1990 Oct; 10(5):297-304. PubMed ID: 1964680
[TBL] [Abstract][Full Text] [Related]
37. Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi.
Bai TR; Bramley AM
Am J Physiol; 1993 May; 264(5 Pt 1):L425-30. PubMed ID: 7684571
[TBL] [Abstract][Full Text] [Related]
38. Furosemide and bumetanide, but not nedocromil sodium, modulate nonadrenergic relaxation in guinea pig trachea in vitro.
Verleden GM; Pype JL; Demedts MG
Am J Respir Crit Care Med; 1994 Jan; 149(1):138-44. PubMed ID: 8111571
[TBL] [Abstract][Full Text] [Related]
39. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.
Ward JK; Belvisi MG; Fox AJ; Miura M; Tadjkarimi S; Yacoub MH; Barnes PJ
J Clin Invest; 1993 Aug; 92(2):736-42. PubMed ID: 8349813
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus.
Barbier AJ; Lefebvre RA
J Pharmacol Exp Ther; 1993 Jul; 266(1):172-8. PubMed ID: 8331556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
